Suppr超能文献

根治性切除术后复发肝细胞癌患者的挽救性肝移植。

Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection.

机构信息

Organ Transplant Center of the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

PLoS One. 2012;7(7):e41820. doi: 10.1371/journal.pone.0041820. Epub 2012 Jul 26.

Abstract

OBJECTIVE

To summarize the experience with salvage liver transplantation (SLT) for patients with recurrent hepatocellular carcinoma (HCC) after primary hepatic resection in a single center.

METHODS

A total of 376 adult patients with HCC underwent orthotopic liver transplantation (OLT) at Organ Transplantation Center, the First Affiliated Hospital of Sun Yat-sen University, between 2004 and 2008. Among these patients, 36 underwent SLT after primary liver curative resection due to intrahepatic recurrence. During the same period, one hundred and forty-seven patients with HCC within Milan criteria underwent primary OLT (PLTW group), the intra-operative and post-operative parameters were compared between these two groups. Furthermore, we compared tumor recurrence and patient survival of patients with SLT to 156 patients with HCC beyond Milan criteria (PLTB group). Cox Hazard regression was made to identify the risk factors for tumor recurrence.

RESULTS

The median interval between initial liver resection and SLT was 35 months (1-63 months). The intraoperative blood loss (P<0.05) and transfusion volume (P<0.05) were larger in the SLT group than in the PLTW group. The operation time was longer in the SLT group (P<0.05). The post-operative complications incidence, tumor recurrence rate, patients' survival rate, and tumor-free survival rate were comparable between these two groups (all P>0.05). When compared to those patients with HCC beyond Milan criteria undergoing primary OLT, patients undergoing SLT achieved a better survival and a lower tumor recurrence. Cox Proportional Hazards model showed that vascular invasion, including macrovascular and microvascular invasion, as well as AFP level >400 IU/L were risk factors for tumor recurrence after LT.

CONCLUSIONS

In comparison with primary OLT, although SLT is associated with increased operation difficulties, it provides a good option for patients with HCC recurrence after curative resection.

摘要

目的

总结中山大学附属第一医院肝移植中心单中心经验,探讨再次肝移植治疗肝癌术后复发的效果。

方法

回顾性分析 2004 年至 2008 年中山大学附属第一医院肝移植中心 376 例成人肝癌患者的临床资料,其中 36 例因肝癌术后复发而行再次肝移植术(挽救性肝移植组,SLT 组),147 例符合米兰标准的肝癌患者行首次标准肝移植术(经典肝移植组,PLTW 组),比较两组患者的术中及术后指标。并将 SLT 组患者的肿瘤复发及生存情况与超出米兰标准的 156 例肝癌患者(经典肝移植组,PLTB 组)进行比较。采用 Cox 比例风险回归模型分析肿瘤复发的危险因素。

结果

SLT 组患者的中位复发时间为首次肝切除术后 35 个月(1-63 个月)。与 PLTW 组相比,SLT 组患者术中出血量(P<0.05)和输血量(P<0.05)较多,手术时间较长(P<0.05)。两组患者的术后并发症发生率、肿瘤复发率、患者生存率和无瘤生存率比较差异均无统计学意义(均 P>0.05)。与 PLTB 组患者相比,SLT 组患者的生存情况更好,肿瘤复发率更低。Cox 比例风险回归模型显示,血管侵犯(包括大血管和微血管侵犯)和 AFP>400 IU/L 是肝移植术后肿瘤复发的危险因素。

结论

与首次肝移植相比,虽然 SLT 手术难度较大,但对于肝癌根治性切除术后复发的患者是一种较好的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb2/3406089/ba756b6d6e3e/pone.0041820.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验